Vor Biopharma, Inc. VOR
NASDAQ · United States · Health Technology
$18.70+0.64 (+3.53%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -1.16 | -0.70 | -64.8% | $0 | — | -4.4%$23.37→$22.34 |
| Q1 2026 | 2026-05-13 | -0.73 | -0.78 | +6.4% | — | — | -8.5%$16.47→$15.07 |
| Q4 2025 | 2026-03-30 | 307.53 | -1.19 | +25,942.9% | — | — | +23.2%$14.48→$17.84 |
| Q3 2025 | 2025-11-13 | -121.63 | -4.10 | -2,866.6% | — | — | -0.5%$10.06→$10.01 |
| Q2 2025 | 2025-08-12 | -251.20 | -11.80 | -2,028.8% | — | — | — |
| Q1 2025 | 2025-05-14 | -5.20 | -4.16 | -25.0% | — | — | — |
| Q4 2024 | 2025-03-20 | -8.80 | -6.13 | -43.6% | — | — | — |
| Q4 2023 | 2024-03-20 | -7.80 | -9.94 | +21.5% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.